Skip to content
DataLookout
Menu

CARTISTEM23-01NCT07339111

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

StatusRecruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 26 versions: 26 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial sites expanded: 35 → 40 locations
  2. Minor Study sites: 35 to 37
  3. Minor Study description expanded, about 105 words
  4. Minor Trial sites expanded: 30 → 35 locations
  5. Minor Study sites: 30 to 31
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Eligibility criteria expanded, about 60 words
    • Study sites: 29 to 30
  2. Minor Study sites: 28 to 29v20
  3. Minor Study sites: 29 to 28v19
  1. Minor Trial sites expanded: 25 → 29 locations
    • Trial sites expanded: 21 → 25 locations
    v18
  2. Minor Study sites: 21 to 25v17
  3. Minor Study sites: 20 to 21v16
  4. Minor Site contacts updated at 1 of 20 sitesv15
  5. Minor Site details revised at 1 of 20 sitesv14
  6. Minor Study sites: 19 to 20v13
  7. Minor Study sites: 17 to 19v12
  8. Minor Study sites: 16 to 17v11
  9. Minor Site details revised at 2 of 16 sitesv10
  10. Minor Trial sites expanded: 13 → 16 locationsv9
  11. Minor Site details revised at 3 of 13 sitesv8
  12. Minor Site details revised at 4 of 13 sitesv7
  13. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 15, 2026 to Mar 11, 2026
    • Site details revised at 13 of 13 sites
    v6
  14. Minor Study sites: 12 to 13v5
  15. Minor Study sites: 11 to 12v4
  16. Notable Enrollment target: 1200 to 300
    • Study sites: 0 to 11
    v3
  17. Notable Start date: Dec 15, 2025 to Feb 15, 2026v2
  18. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Visual Analog Scale (VAS) Pain Score
Timeframe: From enrollment to end of follow-up at 24 months
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC®) Function score
Timeframe: From start of treatment to the end of follow-up at 24 months

Secondary (2)

Modified Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) Score
Change in MRI Osteoarthritis Knee Score (MOAKS) cartilage morphology

Arms and interventions

CARTISTEM + DebridementExperimental

Participants in Group A will receive CARTISTEM + Debridement in the target knee.

DebridementActive comparator

Participants in Group B will receive debridement procedure.

Biologicals: CARTISTEM® + Debridement

Procedures: Debridement

Sites

40 sites in 1 country